CN111544319A - Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof - Google Patents
Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof Download PDFInfo
- Publication number
- CN111544319A CN111544319A CN202010344766.7A CN202010344766A CN111544319A CN 111544319 A CN111544319 A CN 111544319A CN 202010344766 A CN202010344766 A CN 202010344766A CN 111544319 A CN111544319 A CN 111544319A
- Authority
- CN
- China
- Prior art keywords
- component
- parts
- toothpaste
- components
- nisin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000606 toothpaste Substances 0.000 title claims abstract description 43
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 42
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 26
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 26
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title abstract description 8
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims abstract description 13
- 108010053775 Nisin Proteins 0.000 claims abstract description 13
- 239000004309 nisin Substances 0.000 claims abstract description 13
- 235000010297 nisin Nutrition 0.000 claims abstract description 13
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims abstract description 12
- 229940048086 sodium pyrophosphate Drugs 0.000 claims abstract description 11
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims abstract description 11
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 11
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 10
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims abstract description 10
- 239000000600 sorbitol Substances 0.000 claims abstract description 10
- 229960004029 silicic acid Drugs 0.000 claims abstract description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 8
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 8
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940061605 tetrasodium glutamate diacetate Drugs 0.000 claims abstract description 7
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 claims abstract description 7
- PVGBHEUCHKGFQP-UHFFFAOYSA-N sodium;n-[5-amino-2-(4-aminophenyl)sulfonylphenyl]sulfonylacetamide Chemical compound [Na+].CC(=O)NS(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 PVGBHEUCHKGFQP-UHFFFAOYSA-N 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 13
- 102000016943 Muramidase Human genes 0.000 claims description 10
- 108010014251 Muramidase Proteins 0.000 claims description 10
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 10
- 235000010335 lysozyme Nutrition 0.000 claims description 10
- 229960000274 lysozyme Drugs 0.000 claims description 8
- 239000004325 lysozyme Substances 0.000 claims description 8
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 7
- WSELJKAMVUHMJP-PUZYILPLSA-N (2s,3r,4s,5r)-2,3-dichloro-2,3,4,5,6-pentahydroxyhexanoyl chloride Chemical compound OC[C@@H](O)[C@H](O)[C@@](O)(Cl)[C@](O)(Cl)C(Cl)=O WSELJKAMVUHMJP-PUZYILPLSA-N 0.000 claims description 6
- 102000010445 Lactoferrin Human genes 0.000 claims description 6
- 108010063045 Lactoferrin Proteins 0.000 claims description 6
- 239000000679 carrageenan Substances 0.000 claims description 6
- 235000010418 carrageenan Nutrition 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 6
- 235000021242 lactoferrin Nutrition 0.000 claims description 6
- 229940078795 lactoferrin Drugs 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 229940105902 mint extract Drugs 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 229940074046 glyceryl laurate Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 1
- 235000020737 peppermint extract Nutrition 0.000 claims 1
- 206010006326 Breath odour Diseases 0.000 abstract description 28
- 208000032139 Halitosis Diseases 0.000 abstract description 24
- 210000000214 mouth Anatomy 0.000 abstract description 18
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 244000005700 microbiome Species 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 239000010794 food waste Substances 0.000 abstract description 3
- 230000000840 anti-viral effect Effects 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 150000004691 decahydrates Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940051921 muramidase Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MNLRQHMNZILYPY-MDMHTWEWSA-N N-acetyl-alpha-D-muramic acid Chemical compound OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MDMHTWEWSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 229910052749 magnesium Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000001935 peptisation Methods 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Abstract
The invention discloses toothpaste capable of inhibiting helicobacter pylori and a preparation method thereof, wherein the toothpaste comprises the following components in parts by weight: component A27-36.5, component B57-82, component C0.35-1.3; the component A comprises: 25-30 parts of hydrated silica, 1-2.5 parts of glycerol laurate and 1-4 parts of cellulose gum; the component B comprises: sorbitol 40-55, IgY0.1-0.4, sodium pyrophosphate 0.04-0.06, cocamidopropyl betaine 1-2, tetrasodium glutamate diacetate 0.1-0.3, and water 10-15; the component C comprises: tranexamic acid 0.04-0.07, nisin 0.1-0.4. The invention adopts the IgY component to effectively inhibit helicobacter pylori in the oral cavity, thereby relieving and improving the problem of halitosis. The invention also adopts a plurality of food-grade antibacterial and antiviral components, and can simultaneously inhibit microorganisms causing food residue rotting in the oral cavity to cause tooth damage and oral inflammation, thereby further relieving the problem of halitosis.
Description
Technical Field
The invention relates to daily chemical products, in particular to toothpaste, and particularly relates to toothpaste capable of inhibiting helicobacter pylori and a preparation method thereof.
Background
The toothpaste is a common daily chemical product at present, and mainly brushes teeth and oral cavities through the toothbrush, so that the effects of cleaning the teeth and the oral cavities and refreshing breath are achieved. However, with the irregular work and rest habits of people, oral hygiene and other habits, gum inflammation and oral ulcer are easily caused, so that a plurality of toothpaste manufacturers add anti-inflammatory components into toothpaste, so that the toothpaste can directly act on affected parts to achieve the effects of treating and preventing inflammation when in use. However, most of the anti-inflammatory components are medicinal components, and many of the anti-inflammatory components are raw materials of chemical synthesis, so that the long-term use of the anti-inflammatory components can affect the human health.
In addition, people pay more attention to their own image, and in particular, halitosis can greatly reduce the personal image, so that the prevention and treatment of halitosis is one of the urgent needs of people. After the infection of helicobacter pylori, the helicobacter pylori can cause gastritis, periodontitis and the like, so that halitosis is caused, and is very persistent and difficult to remove. In particular, helicobacter pylori can be transmitted through the mouth, and when taken together with a patient infected with helicobacter pylori, it is likely to cause the infection, thereby causing famous bad breath. The helicobacter pylori in the oral cavity is mostly recurrent with the helicobacter pylori in the stomach, and the helicobacter pylori is infectious, once one person is infected, one person is probably infected, and the helicobacter pylori causes family transmission.
Of course, many microorganisms in the oral cavity cause halitosis, such as gram-positive bacteria, staphylococci, streptococci, micrococcus, etc., which mainly cause halitosis, even periodontitis, ulcers, etc., by causing food residues in the oral cavity to spoil.
In view of the above, the need for preventing and treating halitosis has necessitated the suppression of harmful microorganisms in the oral cavity, as well as the suppression of H.pylori, to solve the problem of halitosis relatively comprehensively.
Disclosure of Invention
In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to provide a toothpaste capable of inhibiting helicobacter pylori and a preparation method thereof, which can effectively inhibit helicobacter pylori, thereby avoiding halitosis caused by helicobacter pylori infection.
In order to achieve the aim, the invention provides toothpaste capable of inhibiting helicobacter pylori, which comprises the following components in parts by weight:
component A27-36.5, component B57-82, component C0.35-1.3;
the component A comprises: 25-30 parts of hydrated silica, 1-2.5 parts of glycerol laurate (lauric acid monoglyceride) and 1-4 parts of cellulose gum;
the component B comprises: sorbitol 40-55, IgY0.1-0.4, sodium pyrophosphate 0.04-0.06, cocamidopropyl betaine 1-2, water 10-15, glutamic diacetic acid tetrasodium 0.1-0.3; preferably, the component B also comprises 5-8 parts of glycerin, 0.5-1 part of carrageenan and 0.08-0.12 part of trichlorogalactose;
the component C comprises: tranexamic acid 0.04-0.07, nisin 0.1-0.4; preferably, the component C also comprises 0.1-0.4 of lysozyme and 0.1-0.4 of lactoferrin.
Preferably, the composition also comprises a component D, wherein the component D comprises 0.4-0.8 of mint extract and 0.05-0.08 of essence.
Preferably, the component B comprises the following components in parts by weight: sorbitol 40-55, IgY0.1-0.4, sodium pyrophosphate 0.04-0.06, cocamidopropyl betaine 1-2, water 10-15, glycerol 5-8, carrageenan 0.5-1, trichlorogalactose 0.08-0.12;
preferably, the component C comprises the following components in parts by weight: tranexamic acid 0.04-0.07, nisin 0.1-0.4, lysozyme 0.1-0.4, lactoferrin 0.1-0.4.
The preparation method of the toothpaste comprises the following steps:
s1, taking out the components of the component B in sequence according to the components, and stirring for 1-1.5 hours by ultrasonic waves to ensure that the components are uniformly stirred;
s2, taking out the components of the component A in sequence, ultrasonically stirring for 0.5-1 hour, pouring the stirred mixed solution into a stirrer of S1, uniformly mixing and stirring, and emulsifying;
s3, adding the component C into the stirrer of S2, and continuing stirring for 1-1.5 hours;
s5, homogenizing, and standing for 4-8 hours to obtain the toothpaste.
S4 is also included between S3 and S5, and the component D is poured into a stirrer of S3 and stirred for 0.5 to 1 hour.
The components include, but are not limited to, the following functions:
tetrasodium glutamate diacetate is well soluble in a wide pH range, has strong decontamination capability and can generate synergistic effect with a bactericide in a system.
The sorbitol is mainly used as a conditioning agent, has certain sweet taste and good mouthfeel, and can condition the taste of the toothpaste while preserving moisture.
Hydrated silica, also known as pure latex, hydrated silicon dioxide, charcoal black, hydrated silicic acid, the particles of which can rub against the teeth to better clean them, and also to thicken the toothpaste.
Cocamidopropyl betaine, an amphoteric surfactant, has excellent stability under acidic and alkaline conditions, presents respectively positive and negative polarity, is often used in combination with anionic, cationic and nonionic surfactants, and has good compatibility. The detergent has the advantages of small irritation, easy water dissolution, acid and alkali stability, more foams, strong detergency, excellent thickening property, softness, bactericidal property, antistatic property and hard water resistance. Can obviously improve the softness, the conditioning performance and the low-temperature stability of the toothpaste. In addition, the invention also has the functions of washing, moistening, thickening, antistatic, sterilization and the like.
Cellulose gum, as a binder, is used to "stick" the components together to form a stable paste.
Sodium pyrophosphate, also known as tetrasodium diphosphate, is classified into anhydrous substance and decahydrated substance. The decahydrate is colorless or white crystal or crystalline powder, and the anhydrous substance is white powder, soluble in water, and insoluble in ethanol and other organic solvents. Decahydrate is preferred in the present invention. It can dissolve insoluble salts of calcium and magnesium, thereby improving the detergency to teeth. In addition, sodium pyrophosphate has a deflocculation effect, can emulsify various grease components, can reduce the surface tension and the interfacial tension of the solution, and has a washing assisting effect.
Glyceryl laurate, lauric monoglyceride, also known as lauric monoglyceride, is a lipophilic nonionic surfactant, a compound naturally found in breast milk. The glycerol laurate can play a role in emulsification, is a safe, efficient and broad-spectrum antibacterial agent, is not limited by pH, and still has a good antibacterial effect under a neutral or slightly alkaline condition. The toothpaste can play a good antibacterial effect after being released in the oral cavity, and can be quickly emulsified when being prepared and used.
Tranexamic acid, also known as tranexamic acid, white crystalline powder; no smell, slightly bitter taste. The black-removing and spot-removing efficacy of the vitamin C is about 50 times higher than that of vitamin C, and is about 10 times higher than that of tartaric acid. The invention is mainly used for lightening the dental plaque.
The invention selects helicobacter pylori type IGY which can effectively inhibit helicobacter pylori, thereby inhibiting and improving halitosis caused by helicobacter pylori infection.
Lysozyme, also known as muramidase (muramidase) or N-acetylmuramylohydrolase (N-acetylmuramylolycanohydrolase), is an alkaline enzyme that hydrolyzes mucopolysaccharides in bacteria. Lysozyme dissolves bacteria by breaking the beta-1, 4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in the cell wall, breaking down the cell wall insoluble mucopolysaccharide into soluble glycopeptides, causing the contents of the broken cell wall to escape. Lysozyme can also be directly combined with virus protein with negative charge, and forms a complex with DNA, RNA and apoprotein to inactivate the virus. Thereby inhibiting harmful microorganisms in the oral cavity and relieving halitosis caused by microorganism activity.
Lactoferrin, an important non-heme iron-binding glycoprotein in milk, is a monomeric glycoprotein with bactericidal activity in neutrophil granules. It has broad-spectrum antibacterial, antioxidant, anticancer, immune system regulating, and disease resistance enhancing effects, and can further inhibit microorganisms in oral cavity.
Nisin, also known as nisin, has a strong inhibitory effect on gram-positive bacteria, including staphylococcus, streptococcus, micrococcus, and other pathogens that cause food spoilage and are harmful to human health. If the nisin is added into food in parts per million to parts per million, the nisin can sufficiently inhibit the growth and the propagation of a plurality of gram-positive bacteria causing food spoilage, and is a natural food preservative with high efficiency and no toxicity.
Water as solvent and blender to dissolve and homogenize the water soluble components.
Glycerol is a colorless, odorless, sweet substance in clear, viscous, liquid form, and has high moisturizing effect.
Essence for regulating smell and taste.
Carrageenan, which prevents re-staining, improves the dispersion and storage properties of the toothpaste and also provides a smooth, soft product with improved emulsion stability.
Trichlorogalactose is used as surfactant, dispersant and stabilizer, and can be used for regulating taste, and as correctant and sweetener.
Herba Menthae extract has antiinflammatory, antibacterial, and breath freshening effects.
The invention has the beneficial effects that:
the invention adopts the IgY component to effectively inhibit helicobacter pylori in the oral cavity, thereby relieving and improving the problem of halitosis. The invention also adopts a plurality of food-grade antibacterial and antiviral components, and can simultaneously inhibit microorganisms causing food residue rotting in the oral cavity to cause tooth damage and oral inflammation, thereby further relieving the problem of halitosis.
The invention also has the functions of cleaning the oral cavity, relieving tooth stains, whitening teeth, reducing dental plaque, refreshing breath, refreshing mouth feel, reducing oral bacteria, maintaining the health of teeth and periodontal tissues (including gingiva) and keeping the oral health.
Detailed Description
The invention is further illustrated by the following examples:
the first embodiment is as follows:
the preparation method of the toothpaste of this example is as follows:
s1, taking out the components of the component B in sequence according to the components, and stirring for 1-1.5 hours by ultrasonic waves to ensure that the components are uniformly stirred;
s2, taking out the components of the component A in sequence, ultrasonically stirring for 0.5-1 hour, pouring the stirred mixed solution into a stirrer of S1, uniformly mixing and stirring, and emulsifying;
s3, adding the component C into the stirrer of S2, and continuing stirring for 1-1.5 hours;
s4, pouring the component D into a stirrer of S3, and stirring for 0.5-1 hour; if component D is absent, this step is omitted;
s5, homogenizing, and standing for 4-8 hours to obtain the toothpaste.
Different toothpastes were prepared according to the preparation method of the invention according to table 1:
TABLE 1
After each toothpaste is prepared, the toothpaste is put into a toothpaste tube, and the use amount of the toothpaste is easy to control because the caliber of the toothpaste tube is standard.
Example two:
selecting 100 helicobacter pylori positive patients with halitosis (bad breath or bad smell in oral cavity), dividing 100 non-helicobacter pylori positive and halitosis patients into five groups, wherein each group comprises 20 helicobacter pylori positive patients and 20 non-helicobacter pylori positive and halitosis patients, and respectively designating experiment group 1, experiment group 2, experiment group 3, experiment group 4 and control group, the experiment group 1, experiment group 2, experiment group 3, experiment group 4 and control group respectively correspond to the first toothpaste, second toothpaste, third toothpaste, fourth toothpaste and control group toothpaste in the first embodiment, the toothpaste is used in the morning and evening once every day, and is about one centimeter (about 1 g) every time, the common soft-hair toothbrush is used for brushing teeth for at least 5 minutes every time, the test period is continuous for 8 weeks, statistics of results is carried out once a week, and the statistical results are as follows (table 2):
TABLE 2 (Unit: person)
In table 2, HP represents HP positive patients, and non-HP represents non-HP positive but halitosis patients. The number of people turning to negative is obtained by detecting saliva two hours after tooth brushing through the helicobacter pylori kit, the halitosis is improved to some extent, and the halitosis is obviously improved through the approach of testers and workers (the nose is detected within the range of 10-15 cm in the oral cavity of the testers), and the people can not eat food within two hours after tooth brushing and can only drink clear water. The test time is after evening use every week, and the starting point of the test period is when morning use next week. The criteria for significant improvement in halitosis were the substantial absence of off-flavors or halitosis. The criteria for improvement of bad breath is a significant reduction of bad breath.
As can be seen from the above table, HP-positive patients turned significantly negative after a continuous four week use, and halitosis was greatly improved, with the malodor essentially disappearing in most of the tests after a continuous 8 week use. The principle is mainly to inhibit helicobacter pylori and other microorganisms which can cause fast food decay and oral inflammation, thereby improving the oral environment and fundamentally solving the problem of halitosis.
The invention is not described in detail, but is well known to those skilled in the art.
The foregoing detailed description of the preferred embodiments of the invention has been presented. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.
Claims (10)
1. The toothpaste capable of inhibiting helicobacter pylori is characterized by comprising the following components in parts by weight:
component A27-36.5, component B57-82, component C0.35-1.3;
the component A comprises: 25-30 parts of hydrated silica, 1-2.5 parts of glycerol laurate and 1-4 parts of cellulose gum;
the component B comprises: sorbitol 40-55, IgY0.1-0.4, sodium pyrophosphate 0.04-0.06, cocamidopropyl betaine 1-2, water 10-15, glutamic diacetic acid tetrasodium 0.1-0.3;
the component C comprises: tranexamic acid 0.04-0.07, nisin 0.1-0.4.
2. The toothpaste of claim 1, further comprising component D, wherein component D comprises peppermint extract 0.4-0.8, and flavor 0.05-0.08.
3. The toothpaste according to claim 1, wherein the component B comprises the following components in parts by weight: sorbitol 40-55, IgY0.1-0.4, sodium pyrophosphate 0.04-0.06, cocamidopropyl betaine 1-2, water 10-15, tetrasodium glutamate diacetate 0.1-0.3, glycerol 5-8, carrageenan 0.5-1, and trichlorogalactose 0.08-0.12.
4. The toothpaste according to any one of claims 1 to 3, wherein component C is composed of the following components in parts by weight: tranexamic acid 0.04-0.07, nisin 0.1-0.4, lysozyme 0.1-0.4, lactoferrin 0.1-0.4.
5. The toothpaste according to claim 1, which comprises the following components in parts by weight: hydrated silica 26, glycerol laurate 1, cellulose gum 3, sorbitol 45, igy0.2, sodium pyrophosphate 0.5, cocamidopropyl betaine 1.2, water 13, tetrasodium glutamate diacetate 0.1, tranexamic acid 0.05, nisin 0.2.
6. The toothpaste according to claim 1, which comprises the following components in parts by weight: hydrated silica 30, glyceryl laurate 2, cellulose gum 2, sorbitol 50, IgY0.3, sodium pyrophosphate 0.06, cocamidopropyl betaine 2, water 13, tetrasodium glutamate diacetate 0.25, tranexamic acid 0.07, nisin 0.3.
7. The toothpaste according to claim 4, which comprises the following components in parts by weight: hydrated silica 26, glycerol laurate 1, cellulose gum 3, sorbitol 45, IgY0.2, sodium pyrophosphate 0.5, cocamidopropyl betaine 1.2, water 13, tetrasodium glutamate diacetate 0.1, glycerol 6, carrageenan 0.8, trichlorogalactose 0.08, tranexamic acid 0.05, nisin 0.2, lysozyme 0.2, lactoferrin 0.2, mint extract 0.5, and essence 0.06.
8. The toothpaste according to claim 4, which comprises the following components in parts by weight: 30 parts of hydrated silica, 2 parts of glycerol laurate, 2 parts of cellulose gum, 50 parts of sorbitol, 0.3 part of IgY0, 0.06 part of sodium pyrophosphate, 2 parts of cocamidopropyl betaine, 13 parts of water, 0.25 part of tetrasodium glutamate diacetate, 5-8 parts of glycerol, 0.6 part of carrageenan, 0.12 part of trichlorogalactose, 0.07 part of tranexamic acid, 0.3 part of nisin, 0.4 part of lysozyme, 0.4 part of lactoferrin, 0.8 part of mint extract and 0.08 part of essence.
9. A method of preparing a toothpaste according to any one of claims 1 to 8 comprising the steps of:
s1, taking out the components of the component B in sequence according to the components, and stirring for 1-1.5 hours by ultrasonic waves to ensure that the components are uniformly stirred;
s2, taking out the components of the component A in sequence, ultrasonically stirring for 0.5-1 hour, pouring the stirred mixed solution into a stirrer of S1, uniformly mixing and stirring, and emulsifying;
s3, adding the component C into the stirrer of S2, and continuing stirring for 1-1.5 hours;
s5, homogenizing, and standing for 4-8 hours to obtain the toothpaste.
10. The method of claim 9, further comprising, between S3 and S5, S4, pouring component D into the mixer of S3, and mixing for 0.5 to 1 hour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010344766.7A CN111544319A (en) | 2020-04-27 | 2020-04-27 | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010344766.7A CN111544319A (en) | 2020-04-27 | 2020-04-27 | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111544319A true CN111544319A (en) | 2020-08-18 |
Family
ID=72001532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010344766.7A Pending CN111544319A (en) | 2020-04-27 | 2020-04-27 | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111544319A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111759773A (en) * | 2020-08-13 | 2020-10-13 | 福州幽力克生物科技有限公司 | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1481897A (en) * | 2002-09-10 | 2004-03-17 | 上海高科生物工程有限公司 | Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use |
| CN109908025A (en) * | 2019-04-15 | 2019-06-21 | 广州康云生物科技有限公司 | Application of the glycine betaine in protection lysozyme activity |
| CN110075036A (en) * | 2019-06-17 | 2019-08-02 | 广东天丝饮料有限公司 | Anti- oral helicobacter pylori medicated toothpaste |
| CN110507583A (en) * | 2019-09-27 | 2019-11-29 | 江苏协合转化医学研究院有限公司 | A kind of efficient prevention and control helicobacter pylori fresh breath toothpaste and preparation method thereof |
| CN110934761A (en) * | 2019-12-25 | 2020-03-31 | 拉芳家化股份有限公司 | Oral care composition |
-
2020
- 2020-04-27 CN CN202010344766.7A patent/CN111544319A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1481897A (en) * | 2002-09-10 | 2004-03-17 | 上海高科生物工程有限公司 | Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use |
| CN109908025A (en) * | 2019-04-15 | 2019-06-21 | 广州康云生物科技有限公司 | Application of the glycine betaine in protection lysozyme activity |
| CN110075036A (en) * | 2019-06-17 | 2019-08-02 | 广东天丝饮料有限公司 | Anti- oral helicobacter pylori medicated toothpaste |
| CN110507583A (en) * | 2019-09-27 | 2019-11-29 | 江苏协合转化医学研究院有限公司 | A kind of efficient prevention and control helicobacter pylori fresh breath toothpaste and preparation method thereof |
| CN110934761A (en) * | 2019-12-25 | 2020-03-31 | 拉芳家化股份有限公司 | Oral care composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111759773A (en) * | 2020-08-13 | 2020-10-13 | 福州幽力克生物科技有限公司 | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100294515B1 (en) | Effervescent tablet for oral cleaning and preparation method thereof | |
| ES2370639T3 (en) | ORAL COMPOSITION CONTAINING ENZYMES THAT HAS IMPROVED STABILITY. | |
| NO342401B1 (en) | Legendary and prophylactic composition for oral cavity care | |
| MXPA04011149A (en) | Antibacterial dentifrice exhibiting antiplaque and breath freshening properties. | |
| US11576947B2 (en) | Oral composition and method | |
| CN106619193A (en) | Antibacterial and whitening toothpaste and preparation method thereof | |
| KR20140131631A (en) | Myrrh and mastic oil containing mouthwashes and method for manufacturing the same | |
| US9023323B2 (en) | Oral compositions for prevention and reduction of bacterial adhesion to oral surfaces | |
| JP2006347987A (en) | Composition for oral cavity and method for enhancing foamability of composition for oral cavity | |
| RU2494724C2 (en) | Toothpaste, containing freeze-dried mass of live bifidobacteria | |
| CN111544319A (en) | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof | |
| JPH09249541A (en) | Dentifrice | |
| CN111759773A (en) | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof | |
| JP2011046654A (en) | Dentifrice composition | |
| WO2002067883A1 (en) | Cleansing compositions for oral cavity | |
| CN105832614A (en) | Natural edible toothpaste for children and preparation method | |
| CN103599182A (en) | Traditional Chinese medicine composition and preparation method thereof, and oral cavity cleaning and nursing product and preparation method thereof | |
| JP2020083787A (en) | Composition for oral cavity | |
| JP2001181163A (en) | Composition for oral cavity for removing stain | |
| KR100704585B1 (en) | Toothpaste composition | |
| JPH045222A (en) | Crude drug extract for oral cavity and composition for oral cavity containing the same as active ingredient | |
| JP2005179290A (en) | Dentifrice composition and method for producing the same | |
| JP3022047B2 (en) | Oral composition | |
| CN115177543B (en) | Antibacterial caries preventing composition containing L-lactate, oral care product and preparation method and application thereof | |
| CA1126160A (en) | Pure alkali metal salts of lauryl (dodecyl) sulphate in oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |
|
| RJ01 | Rejection of invention patent application after publication |